linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Tarmat Ltd.
 
Source DateBoard Meeting DateDetails
15 May 202530 May 2025 Audited Results
27 Jan 202514 Feb 2025 Quarterly Results
04 Nov 202414 Nov 2024 Quarterly Results
05 Aug 202414 Aug 2024 Quarterly Results
14 May 202430 May 2024 Audited Results
21 Feb 202424 Feb 2024 Preferential Issue of shares
29 Jan 202414 Feb 2024 Quarterly Results
01 Nov 202314 Nov 2023 Quarterly Results
02 Aug 202314 Aug 2023 Quarterly Results
15 May 202330 May 2023 Audited Results
30 Jan 202314 Feb 2023 Quarterly Results
02 Nov 202214 Nov 2022 Quarterly Results
02 Aug 202213 Aug 2022 Quarterly Results
04 Jul 202207 Jul 2022 Inter alia, to consider, approve and take on record, allotment of 1541569 Equity Shares ( converted out of 1541569 Convertiable warrants) on preferential Basis to Non promoters in accordance with the special resolution passed by the shareholders in the Annual General Meeting of the Company held on September 28,2021, along with the "ln Principal Approval" dated November 23, 2021 received from both the stock exchanges i.e. BSE and NSE.
17 May 202230 May 2022 Audited Results
04 May 202207 May 2022 Preferential Issue of shares
18 Apr 202221 Apr 2022 Preferential Issue of shares Inter alia, to consider, approve and take on record, allotment of 3802576 Equity Shares ( converted out of 3802576 Convertiable warrants) on preferential Basis to Promoters and Non promoters in accordance with the special resolution passed by the shareholders in the Annual General Meeting of the Company held on September 28,2021, along with the "In Principal Approval" dated November 23, 2021 received from both the stock exchanges i.e. BSE and NSE.
04 Feb 202214 Feb 2022 Quarterly Results & Preferential Issue of shares
20 Jan 202225 Jan 2022 Preferential Issue of shares
20 Dec 202123 Dec 2021 Preferential Issue of shares Inter-alia to consider and approve to allot 10,50,000 Converted warrants into equity shares on preferential Basis to Non promoters.
Page 1 of 5
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.